Login / Signup
Vibeke Kruse
ORCID
Publication Activity (10 Years)
Years Active: 2021-2021
Publications (10 Years): 2
Top Topics
Ejection Fraction
Patient Reported Outcomes
Lymph Node Metastasis
Hepatitis C Virus
Top Venues
Acta clinica Belgica
Immunotherapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Michael Saerens
,
Vibeke Kruse
,
Willem Lybaert
Strategies to overcome relapse of immunotherapy-related hepatitis: dose reduction is not the key.
Acta clinica Belgica
(2021)
Stijn Jeroen De Keukeleire
,
Tijl Vermassen
,
Zahra M Nezhad
,
Tessa Kerre
,
Vibeke Kruse
,
Hans Van Vlierberghe
,
Karim Vermaelen
,
Sylvie Rottey
Managing viral hepatitis in cancer patients under immune checkpoint inhibitors: should we take the risk?
Immunotherapy
13 (5) (2021)